APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug-Delivery Coatings for Medical Devices

Drug-delivery coatings for medical devices represent a specialized class of functionalized biomaterials engineered to serve as localized reservoirs for the controlled release of therapeutic agents directly at the site of clinical intervention. These advanced surface modifications typically consist of a polymer matrix—either durable or biodegradable—or a polymer-free topographical architecture designed to encapsulate active pharmaceutical ingredients such as anti-proliferative, anti-thrombogenic, or antimicrobial agents. By modulating the physicochemical properties of the coating interface, these systems achieve precise elution kinetics that maintain therapeutic concentrations within the target tissue while minimizing systemic toxicity and off-target effects. In clinical practice, these coatings are integral to the performance of intravascular stents, drug-coated balloons, and orthopedic implants, where they function to suppress inflammatory responses, prevent restenosis, or inhibit biofilm formation, thereby significantly enhancing the long-term biocompatibility and therapeutic efficacy of the underlying medical hardware.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Drug-delivery coatings for medical devices represent a specialized class of functionalized biomaterials engineered to serve as localized reservoirs for the controlled release of therapeutic agents directly at the site of clinical intervention. These advanced surface modifications typically consist of a polymer matrix—either durable or biodegradable—or a polymer-free topographical architecture designed to encapsulate active pharmaceutical ingredients such as anti-proliferative, anti-thrombogenic, or antimicrobial agents. By modulating the physicochemical properties of the coating interface, these systems achieve precise elution kinetics that maintain therapeutic concentrations within the target tissue while minimizing systemic toxicity and off-target effects. In clinical practice, these coatings are integral to the performance of intravascular stents, drug-coated balloons, and orthopedic implants, where they function to suppress inflammatory responses, prevent restenosis, or inhibit biofilm formation, thereby significantly enhancing the long-term biocompatibility and therapeutic efficacy of the underlying medical hardware.

Selected research

Market Outlook & Growth Opportunities

Global Drug-Delivery Coatings for Medical Devices Market Outlook and Growth Opportunities 2026

3 August 2026190 pages

Choose your research edition.

Industry ResearchDrug-Delivery Coatings for Medical Devices Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug-Delivery Coatings for Medical Devices Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Drug-Delivery Coatings for Medical Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug-Delivery Coatings for Medical Devices Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug-Delivery Coatings for Medical Devices Market Analysis and Forecast 2026-2032171 pages · $4,950 USD

Market perspective

Drug-delivery coatings for medical devices represent a specialized class of functionalized biomaterials engineered to serve as localized reservoirs for the controlled release of therapeutic agents directly at the site of clinical intervention. These advanced surface modifications typically consist of a polymer matrix—either durable or biodegradable—or a polymer-free topographical architecture designed to encapsulate active pharmaceutical ingredients such as anti-proliferative, anti-thrombogenic, or antimicrobial agents. By modulating the physicochemical properties of the coating interface, these systems achieve precise elution kinetics that maintain therapeutic concentrations within the target tissue while minimizing systemic toxicity and off-target effects. In clinical practice, these coatings are integral to the performance of intravascular stents, drug-coated balloons, and orthopedic implants, where they function to suppress inflammatory responses, prevent restenosis, or inhibit biofilm formation, thereby significantly enhancing the long-term biocompatibility and therapeutic efficacy of the underlying medical hardware.

The global Drug-Delivery Coatings for Medical Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Drug-Delivery Coatings for Medical Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Europe market for Drug-Delivery Coatings for Medical Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Asia Pacific market for Drug-Delivery Coatings for Medical Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Drug-Delivery Coatings for Medical Devices market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Drug-Delivery Coatings for Medical Devices market include Surmodics, Surface Solutions Laboratories, Freudenberg Medical, CD Bioparticles, Coating Place, Harland Medical Systems, Hydromer and AST Products, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Drug-Delivery Coatings for Medical Devices market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug-Delivery Coatings for Medical Devices and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug-Delivery Coatings for Medical Devices revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Drug-Delivery Coatings for Medical Devices market.

Drug-Delivery Coatings for Medical Devices Segment by Company

Surmodics

Surface Solutions Laboratories

Freudenberg Medical

CD Bioparticles

Coating Place

Harland Medical Systems

Hydromer

AST Products

Drug-Delivery Coatings for Medical Devices Segment by Type

Non-biodegradable

Biodegradable

Polymer-free

Drug-Delivery Coatings for Medical Devices Segment by Application

Cardiovascular (CV)

Ortho

Onco

Antimicrobial

Drug-Delivery Coatings for Medical Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Drug-Delivery Coatings for Medical Devices status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Drug-Delivery Coatings for Medical Devices key companies, revenue, market share, and recent developments.

3. To split the Drug-Delivery Coatings for Medical Devices breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Drug-Delivery Coatings for Medical Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drug-Delivery Coatings for Medical Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Drug-Delivery Coatings for Medical Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-Delivery Coatings for Medical Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug-Delivery Coatings for Medical Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-Delivery Coatings for Medical Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug-Delivery Coatings for Medical Devices industry.

Chapter 3: Detailed analysis of Drug-Delivery Coatings for Medical Devices company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Drug-Delivery Coatings for Medical Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Drug-Delivery Coatings for Medical Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drug-Delivery Coatings for Medical Devices Industry Trends Table 2. Drug-Delivery Coatings for Medical Devices Industry Drivers Table 3. Drug-Delivery Coatings for Medical Devices Industry Opportunities and Challenges Table 4. Drug-Delivery Coatings for Medical Devices Industry Restraints Table 5. Global Drug-Delivery Coatings for Medical Devices Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drug-Delivery Coatings for Medical Devices Revenue Share by Company (2021-2026) Table 7. Global Drug-Delivery Coatings for Medical Devices Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Drug-Delivery Coatings for Medical Devices Key Company Manufacturing Base & Headquarters Table 9. Global Drug-Delivery Coatings for Medical Devices Company, Product Type & Application Table 10. Global Drug-Delivery Coatings for Medical Devices Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Drug-Delivery Coatings for Medical Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Non-biodegradable Table 15. Significant Companies of Biodegradable Table 16. Significant Companies of Polymer-free Table 17. Global Drug-Delivery Coatings for Medical Devices Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Drug-Delivery Coatings for Medical Devices Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Drug-Delivery Coatings for Medical Devices Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Drug-Delivery Coatings for Medical Devices Sales Value Share by Type (2021-2026) Table 21. Global Drug-Delivery Coatings for Medical Devices Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Cardiovascular (CV) Table 23. Significant Companies of Ortho Table 24. Significant Companies of Onco Table 25. Significant Companies of Antimicrobial Table 26. Global Drug-Delivery Coatings for Medical Devices Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Drug-Delivery Coatings for Medical Devices Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Drug-Delivery Coatings for Medical Devices Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Drug-Delivery Coatings for Medical Devices Sales Value Share by Application (2021-2026) Table 30. Global Drug-Delivery Coatings for Medical Devices Sales Value Share by Application (2027-2032) Table 31. Global Drug-Delivery Coatings for Medical Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Drug-Delivery Coatings for Medical Devices Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Drug-Delivery Coatings for Medical Devices Sales Value Share by Region (2021-2026) Table 34. Global Drug-Delivery Coatings for Medical Devices Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Drug-Delivery Coatings for Medical Devices Sales Value Share by Region (2027-2032) Table 36. Global Drug-Delivery Coatings for Medical Devices Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Drug-Delivery Coatings for Medical Devices Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Drug-Delivery Coatings for Medical Devices Sales Value Market Share by Country (2021-2026) Table 39. Global Drug-Delivery Coatings for Medical Devices Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Drug-Delivery Coatings for Medical Devices Sales Value Market Share by Country (2027-2032) Table 41. Surmodics Company Information Table 42. Surmodics Business Overview Table 43. Surmodics Drug-Delivery Coatings for Medical Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Surmodics Drug-Delivery Coatings for Medical Devices Product Portfolio Table 45. Surmodics Recent Development Table 46. Surface Solutions Laboratories Company Information Table 47. Surface Solutions Laboratories Business Overview Table 48. Surface Solutions Laboratories Drug-Delivery Coatings for Medical Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Surface Solutions Laboratories Drug-Delivery Coatings for Medical Devices Product Portfolio Table 50. Surface Solutions Laboratories Recent Development Table 51. Freudenberg Medical Company Information Table 52. Freudenberg Medical Business Overview Table 53. Freudenberg Medical Drug-Delivery Coatings for Medical Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Freudenberg Medical Drug-Delivery Coatings for Medical Devices Product Portfolio Table 55. Freudenberg Medical Recent Development Table 56. CD Bioparticles Company Information Table 57. CD Bioparticles Business Overview Table 58. CD Bioparticles Drug-Delivery Coatings for Medical Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. CD Bioparticles Drug-Delivery Coatings for Medical Devices Product Portfolio Table 60. CD Bioparticles Recent Development Table 61. Coating Place Company Information Table 62. Coating Place Business Overview Table 63. Coating Place Drug-Delivery Coatings for Medical Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Coating Place Drug-Delivery Coatings for Medical Devices Product Portfolio Table 65. Coating Place Recent Development Table 66. Harland Medical Systems Company Information Table 67. Harland Medical Systems Business Overview Table 68. Harland Medical Systems Drug-Delivery Coatings for Medical Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Harland Medical Systems Drug-Delivery Coatings for Medical Devices Product Portfolio Table 70. Harland Medical Systems Recent Development Table 71. Hydromer Company Information Table 72. Hydromer Business Overview Table 73. Hydromer Drug-Delivery Coatings for Medical Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Hydromer Drug-Delivery Coatings for Medical Devices Product Portfolio Table 75. Hydromer Recent Development Table 76. AST Products Company Information Table 77. AST Products Business Overview Table 78. AST Products Drug-Delivery Coatings for Medical Devices Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. AST Products Drug-Delivery Coatings for Medical Devices Product Portfolio Table 80. AST Products Recent Development Table 81. Research Programs/Design for This Report Table 82. Authors List of This Report Table 83. Secondary Sources Table 84. Primary Sources List of Figures Figure 1. Drug-Delivery Coatings for Medical Devices Product Image Figure 2. Global Drug-Delivery Coatings for Medical Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug-Delivery Coatings for Medical Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug-Delivery Coatings for Medical Devices Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Non-biodegradable Image Figure 8. Biodegradable Image Figure 9. Polymer-free Image Figure 10. Global Drug-Delivery Coatings for Medical Devices Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Drug-Delivery Coatings for Medical Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Drug-Delivery Coatings for Medical Devices Sales Value Share by Type (2021-2032) Figure 13. Cardiovascular (CV) Image Figure 14. Ortho Image Figure 15. Onco Image Figure 16. Antimicrobial Image Figure 17. Global Drug-Delivery Coatings for Medical Devices Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Drug-Delivery Coatings for Medical Devices Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Drug-Delivery Coatings for Medical Devices Sales Value Share by Application (2021-2032) Figure 20. Global Drug-Delivery Coatings for Medical Devices Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Drug-Delivery Coatings for Medical Devices Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Drug-Delivery Coatings for Medical Devices Sales Value (2021-2032) & (US$ Million) Figure 23. North America Drug-Delivery Coatings for Medical Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Drug-Delivery Coatings for Medical Devices Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Drug-Delivery Coatings for Medical Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Drug-Delivery Coatings for Medical Devices Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Drug-Delivery Coatings for Medical Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Drug-Delivery Coatings for Medical Devices Sales Value (2021-2032) & (US$ Million) Figure 29. South America Drug-Delivery Coatings for Medical Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Drug-Delivery Coatings for Medical Devices Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Drug-Delivery Coatings for Medical Devices Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Non-biodegradable
  • Biodegradable
  • Polymer-free
Applications
  • Cardiovascular (CV)
  • Ortho
  • Onco
  • Antimicrobial
Companies covered
  • Surmodics
  • Surface Solutions Laboratories
  • Freudenberg Medical
  • CD Bioparticles
  • Coating Place
  • Harland Medical Systems
  • Hydromer
  • AST Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug-Delivery Coatings for Medical Devices Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug-Delivery Coatings for Medical Devices Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Drug-Delivery Coatings for Medical Devices Market Dynamics
  1. 2.1 Drug-Delivery Coatings for Medical Devices Industry Trends
  2. 2.2 Drug-Delivery Coatings for Medical Devices Industry Drivers
  3. 2.3 Drug-Delivery Coatings for Medical Devices Industry Opportunities and Challenges
  4. 2.4 Drug-Delivery Coatings for Medical Devices Industry Restraints
3 Drug-Delivery Coatings for Medical Devices Market by Company
  1. 3.1 Global Drug-Delivery Coatings for Medical Devices Company Revenue Ranking in 2025
  2. 3.2 Global Drug-Delivery Coatings for Medical Devices Revenue by Company (2021-2026)
  3. 3.3 Global Drug-Delivery Coatings for Medical Devices Company Ranking (2024-2026)
  4. 3.4 Global Drug-Delivery Coatings for Medical Devices Company Manufacturing Base and Headquarters
  5. 3.5 Global Drug-Delivery Coatings for Medical Devices Company Product Type and Application
  6. 3.6 Global Drug-Delivery Coatings for Medical Devices Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Drug-Delivery Coatings for Medical Devices Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Drug-Delivery Coatings for Medical Devices Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Drug-Delivery Coatings for Medical Devices Market by Type
  1. 4.1 Drug-Delivery Coatings for Medical Devices Type Introduction
  2. 4.1.1 Non-biodegradable
  3. 4.1.2 Biodegradable
  4. 4.1.3 Polymer-free
  5. 4.2 Global Drug-Delivery Coatings for Medical Devices Sales Value by Type
  6. 4.2.1 Global Drug-Delivery Coatings for Medical Devices Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Drug-Delivery Coatings for Medical Devices Sales Value by Type (2021-2032)
  8. 4.2.3 Global Drug-Delivery Coatings for Medical Devices Sales Value Share by Type (2021-2032)
5 Drug-Delivery Coatings for Medical Devices Market by Application
  1. 5.1 Drug-Delivery Coatings for Medical Devices Application Introduction
  2. 5.1.1 Cardiovascular (CV)
  3. 5.1.2 Ortho
  4. 5.1.3 Onco
  5. 5.1.4 Antimicrobial
  6. 5.2 Global Drug-Delivery Coatings for Medical Devices Sales Value by Application
  7. 5.2.1 Global Drug-Delivery Coatings for Medical Devices Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Drug-Delivery Coatings for Medical Devices Sales Value by Application (2021-2032)
  9. 5.2.3 Global Drug-Delivery Coatings for Medical Devices Sales Value Share by Application (2021-2032)
6 Drug-Delivery Coatings for Medical Devices Regional Value Analysis
  1. 6.1 Global Drug-Delivery Coatings for Medical Devices Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug-Delivery Coatings for Medical Devices Sales Value by Region (2021-2032)
  3. 6.2.1 Global Drug-Delivery Coatings for Medical Devices Sales Value by Region: 2021-2026
  4. 6.2.2 Global Drug-Delivery Coatings for Medical Devices Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug-Delivery Coatings for Medical Devices Sales Value (2021-2032)
  7. 6.3.2 North America Drug-Delivery Coatings for Medical Devices Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Drug-Delivery Coatings for Medical Devices Sales Value (2021-2032)
  10. 6.4.2 Europe Drug-Delivery Coatings for Medical Devices Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Drug-Delivery Coatings for Medical Devices Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Drug-Delivery Coatings for Medical Devices Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Drug-Delivery Coatings for Medical Devices Sales Value (2021-2032)
  16. 6.6.2 South America Drug-Delivery Coatings for Medical Devices Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Drug-Delivery Coatings for Medical Devices Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Drug-Delivery Coatings for Medical Devices Sales Value Share by Country, 2025 VS 2032
7 Drug-Delivery Coatings for Medical Devices Country-level Value Analysis
  1. 7.1 Global Drug-Delivery Coatings for Medical Devices Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drug-Delivery Coatings for Medical Devices Sales Value by Country (2021-2032)
  3. 7.2.1 Global Drug-Delivery Coatings for Medical Devices Sales Value by Country (2021-2026)
  4. 7.2.2 Global Drug-Delivery Coatings for Medical Devices Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Drug-Delivery Coatings for Medical Devices Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Drug-Delivery Coatings for Medical Devices Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Drug-Delivery Coatings for Medical Devices Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Surmodics
  2. 8.1.1 Surmodics Company Information
  3. 8.1.2 Surmodics Business Overview
  4. 8.1.3 Surmodics Drug-Delivery Coatings for Medical Devices Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Surmodics Drug-Delivery Coatings for Medical Devices Product Portfolio
  6. 8.1.5 Surmodics Recent Developments
  7. 8.2 Surface Solutions Laboratories
  8. 8.2.1 Surface Solutions Laboratories Company Information
  9. 8.2.2 Surface Solutions Laboratories Business Overview
  10. 8.2.3 Surface Solutions Laboratories Drug-Delivery Coatings for Medical Devices Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Surface Solutions Laboratories Drug-Delivery Coatings for Medical Devices Product Portfolio
  12. 8.2.5 Surface Solutions Laboratories Recent Developments
  13. 8.3 Freudenberg Medical
  14. 8.3.1 Freudenberg Medical Company Information
  15. 8.3.2 Freudenberg Medical Business Overview
  16. 8.3.3 Freudenberg Medical Drug-Delivery Coatings for Medical Devices Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Freudenberg Medical Drug-Delivery Coatings for Medical Devices Product Portfolio
  18. 8.3.5 Freudenberg Medical Recent Developments
  19. 8.4 CD Bioparticles
  20. 8.4.1 CD Bioparticles Company Information
  21. 8.4.2 CD Bioparticles Business Overview
  22. 8.4.3 CD Bioparticles Drug-Delivery Coatings for Medical Devices Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CD Bioparticles Drug-Delivery Coatings for Medical Devices Product Portfolio
  24. 8.4.5 CD Bioparticles Recent Developments
  25. 8.5 Coating Place
  26. 8.5.1 Coating Place Company Information
  27. 8.5.2 Coating Place Business Overview
  28. 8.5.3 Coating Place Drug-Delivery Coatings for Medical Devices Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Coating Place Drug-Delivery Coatings for Medical Devices Product Portfolio
  30. 8.5.5 Coating Place Recent Developments
  31. 8.6 Harland Medical Systems
  32. 8.6.1 Harland Medical Systems Company Information
  33. 8.6.2 Harland Medical Systems Business Overview
  34. 8.6.3 Harland Medical Systems Drug-Delivery Coatings for Medical Devices Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Harland Medical Systems Drug-Delivery Coatings for Medical Devices Product Portfolio
  36. 8.6.5 Harland Medical Systems Recent Developments
  37. 8.7 Hydromer
  38. 8.7.1 Hydromer Company Information
  39. 8.7.2 Hydromer Business Overview
  40. 8.7.3 Hydromer Drug-Delivery Coatings for Medical Devices Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hydromer Drug-Delivery Coatings for Medical Devices Product Portfolio
  42. 8.7.5 Hydromer Recent Developments
  43. 8.8 AST Products
  44. 8.8.1 AST Products Company Information
  45. 8.8.2 AST Products Business Overview
  46. 8.8.3 AST Products Drug-Delivery Coatings for Medical Devices Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AST Products Drug-Delivery Coatings for Medical Devices Product Portfolio
  48. 8.8.5 AST Products Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst